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Abstract
Background: delirium is an event leading to negative health outcomes and increased mortality in patients. The aim of this
study is to investigate the incidence, determinants and consequences of post-operative delirium (POD) in older patients
undergoing transcatheter aortic valve implantation (TAVI).
Methods:The TAVI Care and Cure program is a prospective, observational registry in patients referred for TAVI at Erasmus
University Medical Centre. The presence of delirium was evaluated by daily clinical assessment by a geriatrician pre- and up
to 3 days post-TAVI. Mortality data were obtained from the Dutch Civil Registry.
Results: A total of 543 patients underwent TAVI between January 2014 and December 2017. Overall, the incidence of POD
was 14% (75/543 patients) but declined from 18% in 2014 to 7% in 2017 (P = 0.009). Patients who developed POD
were older (81.9± 5.8 versus 78.6± 8.3 years, P < 0.001), had higher prevalence of renal dysfunction and prior stroke (54%
versus 40%, P = 0.02; 31% versus 18%, P = 0.01) and were more often frail (32% versus 25%, P = 0.02). From a procedural
perspective, general anesthesia (odds ratios (OR), 2.31; 95% CI, 1.40–3.83; P = 0.001), non-transfemoral access (OR, 2.37;
95% CI, 1.20–4.70; P = 0.01) and longer procedural time (OR, 1.01; 95% CI, 1.01–1.02; P < 0.001) were significantly
associated with POD. One-year survival rate was 68% among patients who had suffered a POD and was 85% in patients
without a POD (hazard ratio’s 1.8 (95% CI 1.01–3.10), P = 0.045).
Conclusion: POD frequently occurs after TAVI and is associated with increased mortality. It might be speculated that patient
selection and the minimalistic approach of TAVI may reduce the frequency of delirium.
Keywords:aortic stenosis, post-operative delirium, transcatheter aortic valve implantation,mortality
Key points
• Delirium after transcatheter aortic valve implantation (TAVI) occurs frequently.
• Delirium after TAVI is associated with increased mortality.
• Patient selection and minimalistic approach of TAVI may reduce post-operative delirium.
Introduction
The incidence of delirium after transcatheter aortic valve
implantation (TAVI) is reported to vary between 12 and
53% and proved to exert a significant and negative impact
on hospital stay and long-term mortality, especially in frail
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and older patients [1–6]. TAVI is increasingly used to treat
patients with aortic stenosis and as a result of increased
experience, new generation heart valves and minimising
the treatment itself, periprocedural complications have
decreased [7–10]. The impact of better procedural outcomes
on the incidence of post-operative delirium (POD) is thus
far unknown.
Notwithstanding the expansion of the indication of TAVI
to low-risk patients [9], themajority of patients who undergo
TAVI have an advanced age with a high risk of POD given
the presence of substantial co-morbidity and frailty [10–12].
The aim of this study is to investigate the incidence,
determinants and consequences of POD in older patients
undergoing TAVI, as well as the consequences of the changes
in TAVI practice on the incidence on delirium.
Methods
Patient selection
The study population consists of 543 consecutive patients
who received TAVI because of severe aortic stenosis between
January 2014 and December 2018 and who were enrolled in
the TAVI Care and Cure program [13]. In brief, the TAVI
Care and Cure program is a prospective single-center mul-
tidisciplinary observational cohort study that was initiated
in November 2013 and consists of a prospective collection
of a comprehensive set of predefined cardiovascular and
non-cardiovascular data including a comprehensive geriatric
assessment (CGA), baseline characteristics in addition to
procedural and post-operative data of all patients referred
for and treated with TAVI. There were no specific exclusion
criteria. Treatment decision and strategy was decided during
the multidisciplinary heart team meeting (interventional
cardiologists, cardiac surgeons, anesthesiologist, geriatricians
and a TAVI-nurse coordinator) [14, 15].The TAVI Care and
Cure program was approved by the Medical Ethics Commit-
tee of the Erasmus Medical Center (MEC-2014-277) and
was conducted according to the Helsinki Declaration. All
patients provided written informed consent.
Study measurements
Cardiology assessment
Cardiology assessment included patient’s history, presence of
symptoms using the New York Heart Association (NYHA)
and the Canadian Cardiovascular Society (CCS) score, phys-
ical examination, electrocardiogram, transthoracic echocar-
diography, coronary angiography and multislice computed
tomography, as described before [19, 20].
Geriatric assessment
Frailty was defined by the Erasmus Frailty Score (EFS) that
has been reported to be associated with POD and one-year
mortality [12]. The EFS uses five geriatric domains that are
relevant for this specific population; cognition was measured
by the mini-mental state examination [21], strength by
the hand grip strength test [22], (mal) nutrition by the
Malnutrition Universal Screening Tool [23], inactivity in
basic activities of daily living (measured by the Katz index
(Katz activities of daily living (ADL)) [24] and inactivity
in instrumental activities of daily living (measured by the
Lawton and Brody index) [25]. Patients were considered frail
if the score on 3 or more domains were below predefined
standard cut off points [12].
TAVI procedure
TAVI was initially performed under general anesthesia and
from September 2015 onwards under local anesthesia, using
the transfemoral approach as default choice. After TAVI,
patients were admitted to the intensive care unit for early
monitoring for a minimum of 4 h and then transferred, if no
conduction disturbances or hemodynamic events occurred,
to the general cardiology ward with telemonitoring facility.
Delirium assessment and management of delirium
One day before TAVI, all patients were seen by the geriatri-
cian to assess the risk of delirium based on known risk factors
of POD [1, 3]. All patients were given information on symp-
toms of delirium and non-pharmacological intervention for
delirium prevention were taken. From the day of admission
up to 4 days post-TAVI, a geriatrician evaluated patients on a
daily basis. Deliriumwas defined according to theDiagnostic
and Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV).
Delirium features necessary for diagnoses were: acute
onset and fluctuating coarse AND inattention AND/OR
disorganised thinking AND/OR altered level of conscious-
ness AND/OR hallucinations.The diagnosis of delirium was
made by clinical diagnosis of a geriatrician and was based on
the psychiatric examination of the patient. Patients were seen
by a geriatrician at least once a day on a daily basis and besides
the evaluation of the patient, we continuously evaluated with
the nursing staff on the cardiology ward to learn if there was
any fluctuations in symptoms during the day or overnight.
When caregivers of patients were present, we evaluated with
the caregivers symptoms and fluctuations of symptoms.
Severity of delirium was defined by the delirium obser-
vation score [26]. In case of delirium, patients were treated
according to current national guideline ‘Delirium in adults’,
Dutch Geriatrics Society [16].
Outcome measures
The primary objective of this study is the incidence and
predictors of delirium after TAVI. Secondary objective was
the impact of delirium on all-cause mortality within 1 year
after TAVI. The Dutch Civil Registry was used for the
collection of all-cause mortality data.
Data management and statistical analysis
All data were entered into a dedicated online database hosted
on an internal server. Categorical variables are presented
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as numbers and percentages. Differences between patients
with and without delirium were compared with the chi-
square or Fisher’s exact test, as appropriate. Continuous
variables are expressed as means with standard deviation
(±SD) or median values with corresponding interquartile
ranges (IQR). Differences within the two groups were com-
pared using the independent t-test or its non-parametric
equivalents, respectively. Univariate analysis was performed,
variables with a P-value< 0.10 was entered in the multivari-
ate regression models.
For the multivariate model, covariates were opera-
tionalised as follows: (i) prior stroke: transient ischemic
attack or cerebrovascular accident prior to TAVI, (ii)
renal dysfunction: estimated glomerular filtration rate
< 50 mL/min, (iii) limitation of mobility (gait speed):
walking speed< 1.0 m/s; (iv) frailty measured with the
EFS: five component score, frail when three components
are scored below predefined cut off points.
For the outcome incidence of delirium, odds ratios
(OR) and corresponding 95% confidence interval (CI)
were computed with multivariate logistic regression analysis.
We tested multicollinearity for the multivariate regression
model. Obtained variance inflation factor (VIF) values
ranged between 1 and 2. Cox regression analysis was
performed to investigate the association between delirium
and mortality. The multivariate model was based on the
results form a univariate analysis for the outcome ‘one-year
mortality’. Variables with a P-value< 0.10 were entered in
the multivariate regression models. Hazard ratio’s (HR) and
corresponding 95% CI were computed. To investigate the
changes over time, patients were divided into four cohorts,
depending on the year in which the TAVI took place: cohort
1: 2014; cohort 2: 2015; cohort 3: 2016; cohort 4: 2017.
Categorical variables were compared using the chi-square
test, while continuous variables were compared with the
ANOVA test. Statistical significance across the years was
calculated using the chi-square method adjusting the P-
values after the Bonferroni correction for the proportions.
For the continue variables, the Games-Howell method was
used as a post-hoc test. Analyses were performed using SPSS
version 21 for Windows (SPSS, Inc., Chicago, IL).
Results
Patient characteristics
Between January 2014 and December 2017, a total of 543
patients underwent a TAVI for symptomatic aortic valve
stenosis. Clinical baseline characteristics and procedural fea-
tures are shown in Table 1. Mean age of the population was
79.1± 8.0 years and 55% were men. Hypertension (80%),
hypercholesterolemia (65%), atrial fibrillation (32%) and
diabetes mellitus (32%) were prevalent comorbidities. In this
cohort, there were no patients with existing diagnosis of
dementia (diagnosis noted in primary care records or records
from referring hospitals).There were seven patients (=1.3%)
with mild cognitive impairment, but with no interference in
daily activities.
The incidence of delirium was 14% (75/543 patients).
Patients who developed POD were older (82.1± 5.8 versus
78.6± 8.3 years, P < 0.001), had higher prevalence of renal
dysfunction and prior stroke (54% versus 40%, P = 0.02;
31% versus 18%, P = 0.01) and were more often frail
(32% versus 25%, P = 0.02). Cognitive impairment (OR,
2.28; 95% CI, 1.25–4.13; P = 0.007), reduced gait speed
(OR, 3.69; 95% CI, 1.68–10.72; P = 0.02), limitation in
instrumental activities of daily living (IADL) activity (OR,
2.15; 95% CI, 1.16–3.98; P = 0.02) and the presence of
frailty (OR, 2.50; 95% CI, 1.30–4.82; P = 0.006) were
significantly associated with POD (Table 1).
From a procedural perspective, general anesthesia (OR,
2.31; 95% CI, 1.40–3.83; P = 0.001), non-transfemoral
access (OR, 2.37; 95% CI, 1.20–4.70; P = 0.01) and longer
procedural time (OR, 1.01; 95% CI, 1.01–1.02; P < 0.001)
were significantly associated with POD (Table 1).
Information on the onset of POD was available for all
patients. POD occurred on day 0 and 1 in 68% of the
patients. The median onset of POD was day 1 (IQR 0.0–
2.0 days) (Supplementary Material A1). The incidence of
post-procedural stroke (11% versus 3%; P = 0.001), new
pacemaker implantation (24% versus 14%; P = 0.02),
vascular complication (24% versus13%; P = 0.009),
post-operative urinary tract infection (13% versus 2%;
P < 0.001) and post-operative pneumonia (9% versus 4%;
P = 0.03) was higher in patients with POD than those
without POD. Yet, independent variables predicting POD
were found to be prior stroke (OR, 4.29; 95% CI, 1.85–
9.96; P = 0.001), the presence of frailty (OR, 2.37; 95%
CI, 1.12–5.07; P = 0.025) and the length of the procedure
(OR, 1.02; 95% CI, 1.01–1.03; P < 0.001) (Table 2).
The presence of POD was associated with prolonged in-
hospital stay, independent of other periprocedural complica-
tions (uncomplicated TAVI 8.2 versus 7.5 days, P = 0.003
and complicated TAVI 17.8 versus 11.1 days, P < 0.001).
Impact of POD on Mortality during follow-up
Median follow-up was 1.4 years (IQR: 0.6–2.5 years), overall
mortality was 29.5% (n = 190). One-year survival rate was
68% among patients who had suffered POD and 85% in
patients without POD (HR 1.8 (1.01–3.10), P = 0.045)
(Figure 1).
Changes over time
In the period from January 2014 to December 2017, the
mean age, prevalence of frailty and prior stroke of patients
who underwent TAVI remained the same (P = 0.332,
P > 0.999 and P = 0.467, respectively). Yet, the proportion
of patients with renal dysfunction was higher in those
treated in 2014 and 2015 versus those treated in 2016 and
2017 (53% and 52% versus 37% and 32%, respectively,
P < 0.001). The main change was found to be of procedural
nature; the use of general anesthesia fell from 100% in
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Table 1. Baseline characteristics and procedural features of the total study population
Variable (n, %) All patients Delirium Association with delirium
n = 543 Present (n = 75) Absent (n = 468) OR 95% CI P-value
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Male sex (n, %) 297 (55%) 44 (59%) 253 (54%) 0.83 0.51–1.36 0.48
Age (mean± SD) 79.1± 8.0 81.9± 5.8 78.6± 8.3 1.06 1.02–1.10 0.001
BMI (mean, SD) 27.3± 4.9 27.1± 4.2 27.3± 5.1 0.99 0.93–1.05 0.76
Aortic valve area, cm2 0.77± 0.25 0.74± 0.24 0.78± 0.25 0.54 0.18–1.60 0.27
Cardiovascular risk factors
Diabetes mellitus 176 (32%) 20 (27%) 156 (33%) 0.73 0.42–1.26 0.25
Hypertension 432 (80%) 62 (83%) 370 (79%) 1.26 0.67–2.39 0.47
Hypercholesterolemia 352 (65%) 45 (60%) 307 (66%) 0.79 0.48–1.30 0.35
Comorbidities
Prior MI 118 (22%) 18 (24%) 100 (21%) 1.16 0.65–1.06 0.61
Prior stroke 108 (20%) 23 (31%) 85 (18%) 1.92 0.98–3.76 0.01
Renal dysfunction 227 (42%) 40 (54%) 187 (40%) 1.76 1.07–2.88 0.02
COPD 117 (22%) 13 (18%) 104 (22%) 0.74 0.39–1.40 0.35
Symptoms
NYHA classes III/IV 358 (66%) 53 (72%) 305 (65%) 1.34 0.78–2.30 0.25
Angina CCS classes III/IV 64 (13%) 8 (11%) 56 (13%) 0.88 0.40–1.93 0.74
Frailty indices (n = 330)
Cognitive impairment 107 (31%) 26 (48%) 81 (28%) 2.40 1.34–4.39 0.003
Malnutrition probable 38 (11%) 8 (15%) 30 (10%) 1.60 0.69–3.70 0.29
Reduced gait speed 219 (67%) 41 (79%) 178 (38%) 2.09 1.03–4.26 0.04
Reduced muscle strength 160 (48%) 302(62%) 128 (45%) 1.94 1.06–3.55 0.03
Limitation in ADL activity 107 (30.4%) 19 (35%) 88 (30%) 1.30 0.70–2.39 0.41
Limitation in IADL activity 189 (54%) 37 (69%) 152 (51%) 2.09 1.13–3.88 0.02
Frailty identified (EFS) 97 (28.5%) 24 (32%) 71 (25%) 2.60 1.41–4.80 0.002
Procedural features
General anesthesia 232 (43%) 45 (59%) 187 (40%) 2.31 1.40–3.83 0.001
Non-transfemoral access 51 (9%) 13 (17%) 38 (8%) 2.37 1.20–4.70 0.01
Cerebral protection 274 (51%) 36 (49%) 238 (51%) 0.93 0.57–1.53 0.78
Procedure time, minutes (mean± SD) 140± 61.5 184± 93.4 133± 51.6 1.01 1.01–1.02 <0.001
Values are n(%), mean± SD. BMI, body mass index; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease.
Table 2. Predictors for POD within a multivariate model
Variable OR 95% CI P-value
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Age 1.06 0.99–1.13 0.097
Prior stroke 3.10 1.49–6.47 0.003
Renal dysfunction 1.18 0.57–2.48 0.655
Limitation of mobility
(Gait speed)
1.04 0.44–2.46 0.926
Frailty identified (EFS) 2.37 1.12–5.07 0.025
General anesthesia 1.71 0.70–4.20 0.24
Non-transfemoral access 1.07 0.35–3.31 0.905
Procedural time (min) 1.02 1.01–1.03 <0.001
2014 to 19% in 2017 (P < 0.001), non-transfemoral access
dropped from 18% in 2014 to 8% in 2017 (P = 0.08) and
procedure time was reduced from 191.6± 65.7minimum in
2014 to 91.0± 37.8 minimum in cohort 2017 (P < 0.001)
(Supplementary Material A2). During this observation
period, the incidence of delirium decreased from 18% in
2014 to 7% in 2017 (P = 0.009).
Discussion
In this study, we found that delirium frequently occurs
after TAVI in older patients and is associated with increased
Figure 1. One-year mortality of patients with and without
a delirium. One-year mortality of patients with and without
delirium.HR 1.8 (1.01–3.10), P = 0.045. Adjusted for age, sex,
dyslipidemia, atrial fibrillation, New York Heart Association
classes 3 or 4, renal dysfunction
mortality. Frailty and prior stroke as well as procedural time
were independent predictors of POD.
Frailty is known to be a risk factor of POD in patients
undergoing TAVI and can be explained by the fact that
frailty is the result of reduced physical, cognitive and social
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functioning and, thus, associated with a reduction of an
adaptive or reserve capacity in case of stressors [11, 12,
17, 18]. Despite the minimal invasive nature of TAVI, this
procedure remains a stressful event in particular when con-
sidering the profile of patients undergoing TAVI who are in
general old and have multiple comorbidities and frailty. Age
remains and will remain advanced in patients undergoing
TAVI, as shown in this study, in addition to the ageing
society, notwithstanding the expansion of indication of TAVI
to lower risk patients [10].
According with previous studies, we found prior stroke
to be a predictor of POD [1, 2, 5, 19]. In the present
analysis, prior stroke was associated with a 4-fold increased
risk of POD. The risk factors for stroke overlap with those
of cognitive impairment and dementia [20], which are also
associated with increased risk for delirium [12, 21].
Not unexpectedly, procedural factors predicted POD.
Previous studies have shown that the use of general anesthesia
and the non-transfemoral access may lead to a 4-fold increase
on POD [2, 17]. In the present study, we found bymultivari-
able analysis that procedure time was the only independent
procedural factor predicting POD.
There is a still controversy on the effect of the anesthetic
technique (general versus local anesthesia) on POD [2, 22].
General anesthesia has been linked to post-operative cog-
nitive dysfunction, but it has not been shown to have the
same effect on POD, when considering POD a form of
temporary cognitive dysfunction [23]. In the present study,
the use of general anesthesia dropped from 100% in 2014
to 20% in 2017, in conjunction with a similar decrease in
procedure time and a slight increase of transfemoral TAVI
to 92% following a global trend in minimising the invasive
nature of TAVI [24–26]. Yet, the effect of these procedural
changes have not systematically been assessed in relation to
POD, although one intuitively would expect a beneficial
effect on the occurrence of POD, as shown in this study (i.e.
a reduction of >10% over 4 years).
One of the possible confounders in the assessment of
the incidence of POD in the present study is the fact that
the geriatrician assessed the risk of POD before TAVI in
the framework of the TAVI Care and Cure program and
implemented preventive measures if deemed necessary. It has
been shown that preventive strategies can lead to a 30%
reduction in POD [27–29]. We have no control group with
patients who did not receive delirium preventive measures,
and therefore we could not add the presence or absence of
delirium prevention into the multivariate model. Yet, in this
study, we believe that both this delirium preventive strategy
in conjunction with minimising the TAVI procedure to a
PCI-like intervention explains the reduction in POD [30].
In addition to the limitation already addressed above, one
must also acknowledge that the present analysis stems from
a single centre observational study conducted in a tertiary
referral centre. The population and findings may, therefore,
not be representative for a general population of patients.
In addition to observation bias inherent to an obser-
vational study without independent adjudication of out-
comes, some variables associated with POD, such as cog-
nitive impairment and dependence in IADL activity, were
not available for all patients. There were no patients in
the cohort with existing diagnosis of dementia found in
primary care records or records from referring hospitals. We
performed a cognitive analysis in 330 out of 543; therefor,
there is a chance that we underestimated the presence of mild
cognitive impairment in our study cohort.
Concerning the data extracted from our CGA, a com-
plete data set was available in 330 patients. The current
study numbers are based on complete case analysis. There
were no baseline differences on cardiovascular and non-
cardiovascular data between those with and without CGA.
In conclusion, delirium occurs frequently after TAVI in
older patients and is associated with impaired prognosis.
Given the ageing of the general population, the burden of
delirium post-TAVIwill remain amatter of concern notwith-
standing the expansion of TAVI to lower risk patients.
It can be speculated whether patient selection and the
minimalistic approach on TAVI might lower the incidence
of delirium.
Supplementary data: Supplementary data are available in
Age and Ageing online.
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